Ethnic differences in N-glucuronidation of nicotine and cotinine

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1196-1203

  Benowitz, Neal L ^a   Perez Stable, Eliseo J ^a   Fong, Irving ^a   Modin, Gunnard ^a   Herrera, Brenda ^a   Jacob III, Peyton ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; CYTOCHROME P450; NICOTINE;

ADULT; ARTICLE; CIGARETTE SMOKING; DRUG CLEARANCE; DRUG GLUCURONIDATION; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AREA UNDER CURVE; BIOTRANSFORMATION; BODY COMPOSITION; COTININE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCURONIDES; HALF-LIFE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NICOTINE; NICOTINIC AGONISTS;

EID: 0032705773     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Benowitz NL (1996) Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188-204.
2. Benowitz NL and Jacob P III (1994) Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 56:483-493.
3. Benowitz NL, Jacob P III, Fong I and Gupta S (1994) Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 268:296-303.
4. Byrd GD, Chang K, Greene JM and deBethizy JD (1992) Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3′-hydroxycotinine in smokers. Drug Metab Dispos 20:192-197.
5. Caldwell WS, Greene JM, Byrd GD, Chang KM, Uhrig MS and deBethizy JD (1992) Characterization of the glucuronide conjugate of cotinine: A previously unidentified major metabolite of nicotine in smokers' urine. Chem Res Toxicol 5:280-285.
6. Carabello RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, Sharp DJ, Eriksen MP, Pirkle JL and Maurer KR (1998) Racial and ethnic differences in serum cotinine levels of cigarette smokers. J Am Med Assoc 280:135-139.
7. Curvall M, Kazemi-Vala E and Englund G (1991) Conjugation pathways in nicotine metabolism, in Effects of Nicotine on Biological Systems (Adlkofer F and Thurau K eds) pp 69-75, Birkhauser-Verlag, Basel.
8. Evans WE, Relling MV, Rahman A, McLeod HL, Scott EP and Lin J-S (1993) Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans. J Clin Invest 91:2150-2154.
9. Gibson RS (1990) Principles of Nutritional Assessment. Oxford University Press, London, pp 189-193.
10. Green MD and Tephly TR (1998) Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins. Drug Metab Dispos 26:860-867.
11. +-Glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group. Drug Metab Dispos 26:830-837.
12. Jackson PR, Tucker GT and Woods VF (1989) Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism: Histograms and probit plots. Br J Clin Pharmacol 28:647-653.
13. Jacob P III and Benowitz NL (1993) Pharmacokinetics of (S)-nicotine and metabolites in humans, in Nicotine and Related Alkaloids: Absorption, Distribution, Metabolism and Excretion (Gorrod JW and Wahren J eds) pp 197-218, Chapman and Hall, London.
14. Jacob P III, Benowitz NL and Shulgin AT (1988) Synthesis of optically pure deuterium-labelled nicotine, nornicotine and cotinine. J Label Comp Radiopharmaceut 25:1117-1128.
15. Jacob P III, Shulgin A, Yu L and Benowitz NL (1992) Determination of the nicotine metabolite trans-3'-hydroxycotinine in smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring. J Chromatogr 583:145-154.
16. 2 in humans. Biol Mass Spectrom 20:247-252.
17. Kroemer HK and Klotz U (1992) Glucuronidation of drugs: A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 23:292-310.
18. Miners JO and Mackenzie PI (1991) Drug glucuronidation in humane. Pharmacol Ther 51:347-369.
19. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T and Kuroiwa Y (1996a) Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 277:1010-1015.
20. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T and Kuroiwa Y (1996b) Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212-1217.
21. Perez-Stable EJ, Herrera B, Jacob P III and Benowitz NL (1998) Nicotine metabolism and intake in black and white smokers. J Am Med Assoc 280:152-156.
22. Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA and Hecht SS (1997) Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomark Prev 6:783-790.
23. SYSTAT, 7.0 (1997) SPSS, Inc., Chicago.
24. Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH and Jacobs DR (1990) Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults Study. Am J Public Health 80:1053-1056.
25. Yue QY, Svensson JO, Alm C, Sjoqvist F and Sawe J (1989) Interindividual and interethnic differences in demethylation and glucuronidation of codeine. Br J Clin Pharmacol 28:629-637.